Helen J. McBride

1.8k total citations
40 papers, 1.4k citations indexed

About

Helen J. McBride is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Helen J. McBride has authored 40 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 16 papers in Immunology and 14 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Helen J. McBride's work include Monoclonal and Polyclonal Antibodies Research (12 papers), Biosimilars and Bioanalytical Methods (12 papers) and Ion Channels and Receptors (7 papers). Helen J. McBride is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (12 papers), Biosimilars and Bioanalytical Methods (12 papers) and Ion Channels and Receptors (7 papers). Helen J. McBride collaborates with scholars based in United States, Germany and Canada. Helen J. McBride's co-authors include Valerian V. Dolja, James C. Carrington, David J. Stillman, Yaxin Yu, Scott E. Fraser, Stefan Feske, Ziva Weissman, Daniel Kornitzer, Gerald R. Fink and Ken Y. Chan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Helen J. McBride

40 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Helen J. McBride United States 20 806 249 220 199 173 40 1.4k
Nancy Mah Germany 21 1.5k 1.8× 91 0.4× 184 0.8× 82 0.4× 74 0.4× 51 2.0k
Lifeng Pan China 31 1.8k 2.2× 105 0.4× 369 1.7× 148 0.7× 27 0.2× 78 2.7k
Raymond Julien France 22 1.2k 1.5× 122 0.5× 119 0.5× 27 0.1× 49 0.3× 50 1.7k
Clotilde Randriamampita France 23 1.3k 1.6× 41 0.2× 620 2.8× 423 2.1× 71 0.4× 35 2.2k
Ji‐Ming Feng United States 19 582 0.7× 74 0.3× 592 2.7× 129 0.6× 33 0.2× 27 1.3k
Eva C. Schwarz Germany 27 988 1.2× 79 0.3× 607 2.8× 805 4.0× 22 0.1× 49 2.3k
Hans Voshol Switzerland 27 1.5k 1.9× 31 0.1× 364 1.7× 26 0.1× 151 0.9× 45 2.3k
Hongsheng Li China 22 800 1.0× 50 0.2× 119 0.5× 18 0.1× 39 0.2× 73 1.4k
Janet E. McCombs United States 15 1.1k 1.3× 35 0.1× 119 0.5× 27 0.1× 52 0.3× 21 1.4k
B. Wittig Germany 23 2.0k 2.4× 81 0.3× 544 2.5× 30 0.2× 85 0.5× 42 2.8k

Countries citing papers authored by Helen J. McBride

Since Specialization
Citations

This map shows the geographic impact of Helen J. McBride's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Helen J. McBride with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Helen J. McBride more than expected).

Fields of papers citing papers by Helen J. McBride

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Helen J. McBride. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Helen J. McBride. The network helps show where Helen J. McBride may publish in the future.

Co-authorship network of co-authors of Helen J. McBride

This figure shows the co-authorship network connecting the top 25 collaborators of Helen J. McBride. A scholar is included among the top collaborators of Helen J. McBride based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Helen J. McBride. Helen J. McBride is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McBride, Helen J., Vincent Chow, Palanisamy Kanakaraj, et al.. (2021). Non-clinical similarity of biosimilar ABP 798 with rituximab reference product. Biologicals. 72. 42–53. 2 indexed citations
2.
Chow, Vincent, et al.. (2021). Use of nonclinical toxicity studies to support biosimilar antibody development. Regulatory Toxicology and Pharmacology. 122. 104912–104912. 3 indexed citations
3.
Saleem, Ramsey A., Greg Cantin, Mats Wikström, et al.. (2020). Analytical and Functional Similarity Assessment of ABP 710, a Biosimilar to Infliximab Reference Product. Pharmaceutical Research. 37(6). 114–114. 15 indexed citations
4.
Johnson, Ryan, Kang Chen, Eric Tycksen, et al.. (2020). ORAI1 and ORAI2 modulate murine neutrophil calcium signaling, cellular activation, and host defense. Proceedings of the National Academy of Sciences. 117(39). 24403–24414. 37 indexed citations
5.
Wang, Wei, Heather Sweet, Raffi Manoukian, et al.. (2019). Functional and Nonclinical Similarity of ABP 980, a Biosimilar of Trastuzumab. Pharmaceutical Research. 36(12). 177–177. 15 indexed citations
6.
Hao, Yue, Xinchao Yu, Yonghong Bai, Helen J. McBride, & Xin Huang. (2019). Cryo-EM Structure of HER2-trastuzumab-pertuzumab complex. PLoS ONE. 14(5). e0216095–e0216095. 38 indexed citations
7.
Thomas, Michael, Nick Thatcher, Jerome H. Goldschmidt, et al.. (2019). Totality of evidence in development of the bevacizumab biosimilar ABP 215: Central and investigator evaluation of efficacy from the MAPLE study.. Journal of Clinical Oncology. 37(15_suppl). e20708–e20708. 1 indexed citations
8.
Hutterer, Katariina M., et al.. (2019). Assessing Analytical and Functional Similarity of Proposed Amgen Biosimilar ABP 980 to Trastuzumab. BioDrugs. 33(3). 321–333. 25 indexed citations
9.
Márkus, Richárd, Helen J. McBride, Monica Ramchandani, et al.. (2019). A Review of the Totality of Evidence Supporting the Development of the First Adalimumab Biosimilar ABP 501. Advances in Therapy. 36(8). 1833–1850. 24 indexed citations
10.
Kinderman, Francis, Vibha Jawa, Marisa K. Joubert, et al.. (2019). Impact of Precipitation of Antibody Therapeutics After Subcutaneous Injection on Pharmacokinetics and Immunogenicity. Journal of Pharmaceutical Sciences. 108(6). 1953–1963. 22 indexed citations
11.
Greenbaum, Alon, Ken Y. Chan, Tatyana Dobreva, et al.. (2017). Bone CLARITY: Clearing, imaging, and computational analysis of osteoprogenitors within intact bone marrow. Science Translational Medicine. 9(387). 134 indexed citations
12.
McBride, Helen J., et al.. (2017). Functional Similarity of Proposed Biosimilar ABP 798 with Rituximab. Blood. 130. 5001–5001. 1 indexed citations
13.
Guzman, Roberto E., Eliane G. Valente, Efrain Pacheco, et al.. (2014). Expression of ORAI1, a Plasma Membrane Resident Subunit of the CRAC Channel, in Rodent and Non-rodent Species. Journal of Histochemistry & Cytochemistry. 62(12). 864–878. 18 indexed citations
14.
15.
McBride, Helen J.. (2010). Nuclear imaging of autoimmunity: Focus on IBD and RA. Autoimmunity. 43(7). 539–549. 7 indexed citations
16.
Wurz, Ryan P., Liping H. Pettus, Shimin Xu, et al.. (2009). Part 1: Structure–Activity Relationship (SAR) investigations of fused pyrazoles as potent, selective and orally available inhibitors of p38α mitogen-activated protein kinase. Bioorganic & Medicinal Chemistry Letters. 19(16). 4724–4728. 17 indexed citations
17.
McBride, Helen J., et al.. (2003). Wnt signaling components in the chicken intestinal tract. Developmental Biology. 256(1). 18–33. 32 indexed citations
18.
McBride, Helen J., Anita Sil, Vivien Measday, et al.. (2001). The protein kinase Pho85 is required for asymmetric accumulation of the Ash1 protein in Saccharomyces cerevisiae. Molecular Microbiology. 42(2). 345–353. 15 indexed citations
19.
Weissman, Ziva, et al.. (2000). Degradation of the Transcription Factor Gcn4 Requires the Kinase Pho85 and the SCFCDC4Ubiquitin–Ligase Complex. Molecular Biology of the Cell. 11(3). 915–927. 111 indexed citations
20.
McBride, Helen J., Robert Brazas, Yaxin Yu, Kim Nasmyth, & David J. Stillman. (1997). Long-Range Interactions at the HO Promoter. Molecular and Cellular Biology. 17(5). 2669–2678. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nancy Mah Breakdown of academic impact, for papers by Lifeng Pan Breakdown of academic impact, for papers by Raymond Julien Breakdown of academic impact, for papers by Clotilde Randriamampita Breakdown of academic impact, for papers by Ji‐Ming Feng Breakdown of academic impact, for papers by Eva C. Schwarz Breakdown of academic impact, for papers by Hans Voshol Breakdown of academic impact, for papers by Hongsheng Li Breakdown of academic impact, for papers by Janet E. McCombs Breakdown of academic impact, for papers by B. Wittig
Rankless by CCL
2026